High Risk
-
He felt that treatment with monoclonal antibodies has been a little under-emphasized and can be as effective as vaccination at preventing death and hospitalization.
Y0u mentioned this earlier.
The problem is a logistical one. Monoclonal antibodies are not administered as a simple an injection in the deltoid.
(Almost) any idiot can shoot a vaccine into an arm (and not follow protocol for aspirate before you inject, by the way), whereas the infrastructure and staffing needs for widespread monoclonal antibodies are huge. How many trained IV starters do you need in a hospital? At Northwestern, by noon, back in March, they were doing about a thousand injections. No hospital can ramp up that kind of response.
Agree with @George-K’s reply above, which cuts against @Jolly’s characterization that the doc was “even-handed” in his approach to COVID-19.
I also disagree with his claim that the vaccines have been “oversold”. The reports we read, even those in popular press, quite often state that “this vaccine is x% effective against infection,” “that vaccine is y% effective against death and hospitalization.” Those statements quite clearly do not claim “total protection” (x and y are less than 100). These days, more often than not, “total protection” claims show up as straw-man arguments rather than accurate retelling of history.
-
I wonder about #2. I think that the US drugs testing group is the best in the world - a bit conservative but overall, very careful and do an excellent job.
Most people (and many doctors) do not have the experience with the 1000's of drugs out there, so to give them free chance to use drugs in an unknown fashion could be quite dangerous.
-
Florida has been very successful with monoclonal antibody infusion centers. How good do you have to be to slide a Jelco into a median cubital vein?
“Cry havoc and let slip the DOGE of war!”
Those who cheered as J-6 American prisoners were locked in solitary for 18 months without trial, now suddenly fight tooth and nail for foreign terrorists’ "due process". — Buck Sexton
-
-
He felt that treatment with monoclonal antibodies has been a little under-emphasized and can be as effective as vaccination at preventing death and hospitalization.
Y0u mentioned this earlier.
The problem is a logistical one. Monoclonal antibodies are not administered as a simple an injection in the deltoid.
(Almost) any idiot can shoot a vaccine into an arm (and not follow protocol for aspirate before you inject, by the way), whereas the infrastructure and staffing needs for widespread monoclonal antibodies are huge. How many trained IV starters do you need in a hospital? At Northwestern, by noon, back in March, they were doing about a thousand injections. No hospital can ramp up that kind of response.
Agree with @George-K’s reply above, which cuts against @Jolly’s characterization that the doc was “even-handed” in his approach to COVID-19.
I also disagree with his claim that the vaccines have been “oversold”. The reports we read, even those in popular press, quite often state that “this vaccine is x% effective against infection,” “that vaccine is y% effective against death and hospitalization.” Those statements quite clearly do not claim “total protection” (x and y are less than 100). These days, more often than not, “total protection” claims show up as straw-man arguments rather than accurate retelling of history.
He felt that treatment with monoclonal antibodies has been a little under-emphasized and can be as effective as vaccination at preventing death and hospitalization.
Y0u mentioned this earlier.
The problem is a logistical one. Monoclonal antibodies are not administered as a simple an injection in the deltoid.
(Almost) any idiot can shoot a vaccine into an arm (and not follow protocol for aspirate before you inject, by the way), whereas the infrastructure and staffing needs for widespread monoclonal antibodies are huge. How many trained IV starters do you need in a hospital? At Northwestern, by noon, back in March, they were doing about a thousand injections. No hospital can ramp up that kind of response.
Agree with @George-K’s reply above, which cuts against @Jolly’s characterization that the doc was “even-handed” in his approach to COVID-19.
I also disagree with his claim that the vaccines have been “oversold”. The reports we read, even those in popular press, quite often state that “this vaccine is x% effective against infection,” “that vaccine is y% effective against death and hospitalization.” Those statements quite clearly do not claim “total protection” (x and y are less than 100). These days, more often than not, “total protection” claims show up as straw-man arguments rather than accurate retelling of history.
If you had a brain, you'd be dangerous.
-
Florida has been very successful with monoclonal antibody infusion centers. How good do you have to be to slide a Jelco into a median cubital vein?
Florida has been very successful with monoclonal antibody infusion centers. How good do you have to be to slide a Jelco into a median cubital vein?
Pharmacy employees in the likes of CVS and Walgreens can administer vaccine shots. Can they slide a Jelco into a median cubical vein to administer monoclonal antibody?
-
Florida has been very successful with monoclonal antibody infusion centers. How good do you have to be to slide a Jelco into a median cubital vein?
Pharmacy employees in the likes of CVS and Walgreens can administer vaccine shots. Can they slide a Jelco into a median cubical vein to administer monoclonal antibody?
Pharmacy employees in the likes of CVS and Walgreens can administer vaccine shots. Can they slide a Jelco into a median cubical vein to administer monoclonal antibody?
You're talking about a vastly greater skillset.
Vastly.
Starting an IV is nothing like giving an injection.
Nothing.
The only thing they have in common is that sharp things are being used.
I have no idea how long it takes to administer a dose of monoclonal antibody, but rather than taking seconds (as an injection), an infusion is probably more than 10 minutes. Places like pharmacies simply do not have the infrastructure to do this type of thing.
It's a great idea, but functionally beyond impractical.
-
I know one person who had the monoclonal antibodies and I've had experience with infusion centers. I think it is fine for those at high risk, but it is not a panacea due to both supply and process.
“I am fond of pigs. Dogs look up to us. Cats look down on us. Pigs treat us as equals.” ~Winston S. Churchill
-
I’m glad that the Regeneron treatment is available and effective, I just wonder why people that are against the vaccine are against having this crap pumped into you.
-
I know one person who had the monoclonal antibodies and I've had experience with infusion centers. I think it is fine for those at high risk, but it is not a panacea due to both supply and process.
I know one person who had the monoclonal antibodies and I've had experience with infusion centers. I think it is fine for those at high risk, but it is not a panacea due to both supply and process.
Then ramp up production and remake the process.
No, it's never going to be as easy as giving a shot. OTOH, training is very minimal for people who are familiar with starting IV's or performing phlebotomies. And there are a lot of people out there with that skill level.
